
Releases
Spiro Medical Trials Neuromodulation for Severe Asthma
A patient suffering from severe, uncontrolled asthma has received an experimental implant in the PULSAR feasibility study. Conducted at the University of Florida, the trial marks the first time Spiro Medical has applied its neuromodulation platform to address respiratory hyper-responsiveness that remains resistant to standard pharmacological and biologic therapies.


























